Amsterdam Molecular Therapeutics
Verdict on AMT’s gene therapy expected soon
May 11, 2011Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes
Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …
Professor Sander van Deventer appointed to AMT supervisory board
May 10, 2010Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development
Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
